MedPath

Clinical trials of Kushtadi Churna Vati in Diabetes.

Phase 1/2
Completed
Conditions
Type 2 diabetes mellitus without complications,
Registration Number
CTRI/2019/01/017351
Lead Sponsor
The Principal MAMs Sumatibhai Shah Ayurved College
Brief Summary

Randomized controlled trial of Kushtadi Churna Vati as an add-on effect in the management of Madhumeha. Diabetes mellitus is a long term metabolic disorder that is characterized by high blood sugar, insulin resistance and relative lack of insulin. We have developed newer medicines ,but we come across limitations of OHA, therefore there is a need for traditional need for the better management of DM. Considering all above things the study will be carried out in comparison with conventional modern treatment. Patients will be divided in two groups containing 30 each. All the drugs having Pramehaghna properties as well as having Kaphahara, vatahara, Medohara and kledashoshak properties. Thus they can be helpful in reducing the symptoms and Samprapti Vighatan of the disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria
  • A known Diabetic on treatmenet and a newly diagnosed Diabetes.
  • Patient with fasting blood sugar upto 220mg% and post prandial blood sugar upto 300mg% 3.patient having HBA1C upto 10 4.Patient having fasting blood sugar in between 221 to 250 and post prandial 301 ton 350 will be included , if HBA1C is upto 10.
  • If the patient is taking ayurvedic medicine for Madhumeha , washing period for them will be 8 days.
Exclusion Criteria
  • Patients with fasting blood sugar above 220 mg% and post prandial blood sugar above 300mg%.
  • Patient who is already taking Ayurvedic management for Madhumeha.
  • Diabetes Mellitus Type-I ,Acromegaly, Cushing’s syndrome and pancreatic disorder.
  • Those who are under Insulin therapy.
  • Pregnant and lactating mothers.
  • Patients with acute complications like Hyperglycemic coma, Ketoacidosis and infections like gangrene.
  • Patients with K/C/O Nephropathy, Neuropathy and Retinopathy.
  • Patients with gastrointestinal diseases, Liver diseases, tumors, conditions like cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Kushtadi Churna Vati in Madhumeha.3 months
Secondary Outcome Measures
NameTimeMethod
1)To evaluate the efficacy of Kushtadi Churna Vati in Madhumeha on the basis of subjective parameters.2)To evaluate the efficacy of Kushtadi Churna vati in reducing the elevated Blood Sugar Levels in Madhumeha in fasting state.

Trial Locations

Locations (1)

Sumatibhai Shah Ayurved College, Sanegurujin Arogya Kendra

🇮🇳

Pune, MAHARASHTRA, India

Sumatibhai Shah Ayurved College, Sanegurujin Arogya Kendra
🇮🇳Pune, MAHARASHTRA, India
Dr Shweta Lade
Principal investigator
9822214221
ladeshweta1992@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.